Skip to main content
Terug
JMPLF logo

Johnson Matthey Plc

Datakwaliteit: 100%
Oversold
JMPLF
OTC Basic Materials Chemicals - Specialty
€ 25,19
€ 0,00 (0,00%)
Marktkapitalisatie: 4,22B
Ook genoteerd als JMPLY OTC
Dagbereik
€ 25,19 € 29,78
52-Weeksbereik
€ 15,00 € 31,65
Volume
100
50D / 200D Gem.
€ 29,04 / € 26,74
Vorige Slotkoers
€ 25,19

Koershistorie

Financiële Trends

Sectorvergelijking

vs Basic Materials sector mediaan (466 peers)

Metriek Aandeel Sector Mediaan
P/E 11,3 2,3
P/B 1,8 1,7
ROE % 16,0 6,2
Net Margin % 3,2 5,4
Rev Growth 5Y % -6,7 4,7
D/E 0,7 0,4

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 1,89
€ 1,68 – € 2,13
 2,3 B 1
FY2029 € 1,64
€ 1,46 – € 1,85
 2,5 B 1
FY2028 € 1,74
€ 1,55 – € 1,97
 2,5 B 1

Belangrijkste Punten

Revenue declined -6,74% annually over 5 years
Earnings grew 245,37% over the past year
ROE of 15,96% — decent returns on equity
Generating 8,00M in free cash flow
P/E of 11,31 — trading at a low valuation
PEG of 0,02 suggests growth is underpriced

Groei

Revenue Growth (5Y)
-6,74%
Revenue (1Y)-9,10%
Earnings (1Y)245,37%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
15,96%
ROIC10,09%
Net Margin3,20%
Op. Margin4,61%

Veiligheid

Debt / Equity
0,74
Current Ratio1,42
Interest Coverage4,17

Waardering

P/E Ratio
11,31
P/B Ratio1,84
EV/EBITDA9,34
Dividend Yield0,06%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -9,10% Revenue Growth (3Y) -11,58%
Earnings Growth (1Y) 245,37% Earnings Growth (3Y) 16,25%
Revenue Growth (5Y) -6,74% Earnings Growth (5Y) 16,14%
Profitability
Revenue (TTM) 11,67B Net Income (TTM) 373,00M
ROE 15,96% ROA 6,02%
Gross Margin 7,70% Operating Margin 4,61%
Net Margin 3,20% Free Cash Flow (TTM) 8,00M
ROIC 10,09% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,74 Current Ratio 1,42
Interest Coverage 4,17 Dividend Yield 0,06%
Valuation
P/E Ratio 11,31 P/B Ratio 1,84
P/S Ratio 0,36 PEG Ratio 0,02
EV/EBITDA 9,34 Dividend Yield 0,06%
Market Cap 4,22B Enterprise Value 5,03B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 11,67B 12,84B 14,93B 16,03B 15,44B
Net Income 373,00M 108,00M 276,00M -101,00M 205,00M
EPS (Diluted) 2,11 0,59 1,41 -0,53 1,06
Gross Profit 899,00M 927,00M 989,00M 1,05B 944,00M
Operating Income 538,00M 249,00M 505,00M 503,00M 488,00M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6,19B 6,34B 7,03B 6,67B 7,74B
Total Liabilities 3,90B 3,96B 4,49B 4,23B 5,06B
Shareholders' Equity 2,30B 2,38B 2,54B 2,44B 2,69B
Total Debt 1,70B 1,49B 1,67B 1,25B 1,38B
Cash & Equivalents 898,00M 542,00M 650,00M 391,00M 581,00M
Current Assets 3,51B 3,66B 4,37B 4,18B 4,87B
Current Liabilities 2,48B 2,52B 2,89B 3,15B 3,60B

Strategiescores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Contrarian Investing (David Dreman)
#585 of 670
7

Recente Activiteit

Ingestapt Contrarian Investing (David Dreman)
Mar 24, 2026